Skip to Main Content

Paper Details

Changes in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) initiative.
Am Heart J
11
2010
GP IIb/IIIa, Glycoprotein (GP) IIb/IIIa, Glycoprotein IIb/IIIa, Unstable angina, glycoprotein IIb/IIIa, non-ST-segment elevation acute coronary syndromes, patients, women

Datasets